相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发,品质稳、品类全,实验不再等!Takara 秋促来袭,提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ¥1200阿拉丁 22万+ 科研级产品现货速发,品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Influenza A H10N8 (A/Jiangxi-Donghu/346/2013) Hemagglutinin / HA Protein (Catalog#40359-V08B)
- 亚型:
Rabbit IgG
- 形态:
液体
- 保存条件:
-20℃ to -80℃
- 克隆性:
兔单抗
- 适应物种:
H10N8
- 保质期:
12个月
- 抗原来源:
40359-V08B
- 目录编号:
40359-R137
- 级别:
免疫学试剂
- 库存:
99
- 供应商:
北京义翘神州科技股份有限公司
- 宿主:
Rabbit
- 应用范围:
ELISA
- 浓度:
ELISA: 1:5000-1:10000
- 靶点:
HA
- 抗体英文名:
H10N8 (A/Jiangxi-Donghu/346/2013) HA, Rabbit MAb
- 抗体名:
甲型流感H10N8 (A/Jiangxi-Donghu/346/2013)血凝素兔单抗
- 规格:
20.00 µL/50.00 µL/100.00 µL
| 规格: | 20.00 µL | 产品价格: | ¥800.0 |
|---|---|---|---|
| 规格: | 50.00 µL | 产品价格: | ¥1500.0 |
| 规格: | 100.00 µL | 产品价格: | ¥2500.0 |
抗体种属:H10N8
抗体靶点:HA
抗体应用:ELISA
抗原货号:40359-V08B
抗原描述:Recombinant Influenza A H10N8 (A/Jiangxi-Donghu/346/2013) Hemagglutinin / HA Protein (Catalog#40359-V08B)
抗体宿主:Rabbit
抗体Ig类型:Rabbit IgG
抗体纯化方法:Protein A
抗体制备:This antibody was obtained from a rabbit immunized with purified, recombinant H10N8 Influenza A H10N8 (A/Jiangxi-Donghu/346/2013) Hemagglutinin / HA (Catalog#40359-V08B; EPI497477; Met1-Asp524).
特异性:Influenza A H10N8 (A/Jiangxi-Donghu/346/2013) Hemagglutinin / HA
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验A Brief Introduction to the Avian Influenza Virus
in [1 ]). Type A influenza strains are classified by the serological subtypes of the primary viral surface proteins, the hemagglutinin (HA) and neuraminidase (NA). The HA has 16 subtypes (H1–H16) and contains neutralizing epitopes. Antibodies against the NA
Detection and Identification of the H5 Hemagglutinin Subtype by Real-Time RT-PCR
Serological methods, gene sequencing, and RT-PCR-based methods have all been used for the identification of influenza virus hemagglutinin (HA) subtypes. Compared to serological methods and gene sequencing, RT-PCR is fast, sensitive
国自然/高分文章利器!CRISPR文库筛选保姆级指南:从Cas9递送到表型选择一文打通!
-1 2、靶向E2F8通过破坏RRM2驱动的DNA修复增敏吉西他滨耐药的胆囊癌对PARP抑制剂的疗效 发表期刊:Journal of Experimental & Clinical Cancer Research 研究机构:复旦大学附属中山医院 研究人员在吉西他滨耐药的NOZ-R胆囊癌细胞中进行了全基因组CRISPR ko筛选(GeCKO v2文库)。敲除转录因子E2F8可显著增强耐药细胞对PARP抑制剂奥拉帕尼的敏感性。机制上,E2F8通过转录上调RRM
技术资料暂无技术资料 索取技术资料










